Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's Disease
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2021
Price :
$35
*
At a glance
- Drugs Droxidopa (Primary)
- Indications Fatigue; Parkinson's disease
- Focus Therapeutic Use
- 15 Nov 2021 Status changed from recruiting to discontinued.
- 03 Feb 2017 New trial record